.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Dow
Johnson and Johnson
Merck
Novartis
QuintilesIMS
Deloitte
Mallinckrodt
Colorcon
Daiichi Sankyo

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201689

« Back to Dashboard

NDA 201689 describes IFOSFAMIDE, which is a drug marketed by Fresenius Kabi Usa, Mylan Labs Ltd, Teva Pharms Usa, and West-ward Pharms Int, and is included in six NDAs. It is available from six suppliers. Additional details are available on the IFOSFAMIDE profile page.

The generic ingredient in IFOSFAMIDE is ifosfamide; mesna. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ifosfamide; mesna profile page.

Summary for 201689

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 201689

Mechanism of ActionAlkylating Activity

Suppliers and Packaging for NDA: 201689

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IFOSFAMIDE ifosfamide INJECTABLE;INJECTION 201689 ANDA Pfizer Laboratories Div Pfizer Inc. 0069-4495 0069-4495-22 20 mL in 1 VIAL (0069-4495-22)
IFOSFAMIDE ifosfamide INJECTABLE;INJECTION 201689 ANDA Pfizer Laboratories Div Pfizer Inc. 0069-4496 0069-4496-22 60 mL in 1 VIAL (0069-4496-22)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1GM/20ML (50MG/ML)
Approval Date:Nov 26, 2012TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength3GM/60ML (50MG/ML)
Approval Date:Nov 26, 2012TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Citi
Moodys
Federal Trade Commission
Novartis
Colorcon
Argus Health
Medtronic
Merck
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot